Skip to main content
Richard Whittington, MD, Internal Medicine, Sandy, UT

RichardAdairWhittingtonMD

Internal Medicine Sandy, UT

Physician

Dr. Whittington is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Whittington's full profile

Already have an account?

  • Office

    9844 S 1300 E
    200
    Sandy, UT 84094
    Phone+1 801-572-1472
    Fax+1 801-501-2107

Summary

  • Dr. Richard Whittington, MD, is an Internal Medicine specialist based in Sandy, UT. He completed his residency at the McGaw Medical Center of Northwestern University from 1994 to 1998, following a degree from Southern Illinois University School of Medicine. Dr. Whittington has also contributed to medical literature, notably with the publication of 'The PATHFINDER Study' in 'Cancers', which has been cited 67 times by other publications and 'One-on-one care management and procurement of Naloxone for ambulatory use' in 'Journal of Public Health' which has been cited 5 times by other publications.

Education & Training

  • McGaw Medical Center of Northwestern University
    McGaw Medical Center of Northwestern UniversityResidency, Internal Medicine, 1994 - 1998
  • Southern Illinois University School of Medicine
    Southern Illinois University School of MedicineClass of 1994

Certifications & Licensure

  • UT State Medical License
    UT State Medical License 1998 - 2026
  • IL State Medical License
    IL State Medical License 1994 - 1999
  • American Board of Internal Medicine Internal Medicine

Publications & Presentations

PubMed

Journal Articles

  • One-on-One Care Management and Procurement of Naloxone  
    Whittington,R, Whittington, K, Whittington, J, et al., Journurn of Public Health, 2/2018

Abstracts/Posters

  • Abstract CT 291: The Pathfinder Study: Assessment of the Implementation of an investigational multi-cent early detection test into clinical practice
    Naudauld, Lincoln, Whittington R, et al, Cancer Res (2020) 80 (16_Supplement): CT291., 8/2020

Professional Memberships